Skip to main content
Top
Published in: Clinical Reviews in Allergy & Immunology 3/2015

01-12-2015

The Differential Diagnosis of Dry Eyes, Dry Mouth, and Parotidomegaly: A Comprehensive Review

Authors: Divi Cornec, Alain Saraux, Sandrine Jousse-Joulin, Jacques-Olivier Pers, Sylvie Boisramé-Gastrin, Yves Renaudineau, Yves Gauvin, Anne-Marie Roguedas-Contios, Steeve Genestet, Myriam Chastaing, Béatrice Cochener, Valérie Devauchelle-Pensec

Published in: Clinical Reviews in Allergy & Immunology | Issue 3/2015

Login to get access

Abstract

Primary Sjögren’s syndrome (pSS) is a frequent autoimmune systemic disease, clinically characterized by eyes and mouth dryness in all patients, salivary gland swelling or extraglandular systemic manifestations in half of the patients, and development of lymphoma in 5 to 10 % of the patients. However, patients presenting with sicca symptoms or salivary gland swelling may have a variety of conditions that may require very different investigations, treatments, or follow-up. Eye and/or mouth dryness is a frequent complaint in clinical setting, and its frequency increases with age. When evaluating a patient with suspected pSS, the first step is to rule out its differential diagnoses, before looking for positive arguments for the disease. Knowledge of normal and abnormal lachrymal and salivary gland physiology allows the clinician to prescribe the most adapted procedures for evaluating their function and structure. New tests have been developed in recent years for evaluating these patients, notably new ocular surface staining scores or salivary gland ultrasonography. We describe the different diagnoses performed in our monocentric cohort of 240 patients with suspected pSS. The most frequent diagnoses are pSS, other systemic autoimmune diseases, idiopathic sicca syndrome and drug-induced sicca syndrome. However, other diseases are important to rule out due to their specific management, such as sarcoidosis, granulomatosis with polyangeitis, IgG4-related disease, chronic hepatitis C virus or human immunodeficiency virus infections, graft-versus-host disease, and head and neck radiation therapy. At the light of these data, we propose a core of minimal investigations to be performed when evaluating a patient with suspected pSS.
Literature
2.
go back to reference Dupond J-L (2011) Fatigue in patients with rheumatic diseases. Jt Bone Spine Rev Rhum 78:156–160CrossRef Dupond J-L (2011) Fatigue in patients with rheumatic diseases. Jt Bone Spine Rev Rhum 78:156–160CrossRef
3.
go back to reference Youinou P, Devauchelle-Pensec V, Pers J-O (2010) Significance of B cells and B cell clonality in Sjögren’s syndrome. Arthritis Rheum 62:2605–2610CrossRefPubMed Youinou P, Devauchelle-Pensec V, Pers J-O (2010) Significance of B cells and B cell clonality in Sjögren’s syndrome. Arthritis Rheum 62:2605–2610CrossRefPubMed
4.
go back to reference Binard A, Devauchelle-Pensec V, Fautrel B, Jousse S, Youinou P, Saraux A (2007) Epidemiology of Sjögren’s syndrome: where are we now? Clin Exp Rheumatol 25:1–4PubMed Binard A, Devauchelle-Pensec V, Fautrel B, Jousse S, Youinou P, Saraux A (2007) Epidemiology of Sjögren’s syndrome: where are we now? Clin Exp Rheumatol 25:1–4PubMed
5.
go back to reference Vitali C, Bombardieri S, Jonsson R et al (2002) Classification criteria for Sjögren’s syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 61:554–558PubMedCentralCrossRefPubMed Vitali C, Bombardieri S, Jonsson R et al (2002) Classification criteria for Sjögren’s syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 61:554–558PubMedCentralCrossRefPubMed
6.
go back to reference Shiboski SC, Shiboski CH, Criswell LA et al (2012) American College of Rheumatology classification criteria for Sjögren’s syndrome: a data‐driven, expert consensus approach in the Sjögren’s International Collaborative Clinical Alliance Cohort. Arthritis Care Res 64:475–487CrossRef Shiboski SC, Shiboski CH, Criswell LA et al (2012) American College of Rheumatology classification criteria for Sjögren’s syndrome: a data‐driven, expert consensus approach in the Sjögren’s International Collaborative Clinical Alliance Cohort. Arthritis Care Res 64:475–487CrossRef
7.
go back to reference Vitali C, Bootsma H, Bowman SJ et al (2013) Classification criteria for Sjogren’s syndrome: we actually need to definitively resolve the long debate on the issue. Ann Rheum Dis 72:476–478CrossRefPubMed Vitali C, Bootsma H, Bowman SJ et al (2013) Classification criteria for Sjogren’s syndrome: we actually need to definitively resolve the long debate on the issue. Ann Rheum Dis 72:476–478CrossRefPubMed
8.
go back to reference Rasmussen A, Ice JA, Li H et al (2014) Comparison of the American-European Consensus Group Sjögren’s syndrome classification criteria to newly proposed American College of Rheumatology criteria in a large, carefully characterised sicca cohort. Ann Rheum Dis 73:31–38CrossRefPubMed Rasmussen A, Ice JA, Li H et al (2014) Comparison of the American-European Consensus Group Sjögren’s syndrome classification criteria to newly proposed American College of Rheumatology criteria in a large, carefully characterised sicca cohort. Ann Rheum Dis 73:31–38CrossRefPubMed
9.
go back to reference Bowman SJ, Fox RI (2014) Classification criteria for Sjogren’s syndrome: nothing ever stands still! Ann Rheum Dis 73:1–2CrossRefPubMed Bowman SJ, Fox RI (2014) Classification criteria for Sjogren’s syndrome: nothing ever stands still! Ann Rheum Dis 73:1–2CrossRefPubMed
10.
go back to reference Cornec D, Saraux A, Cochener B et al (2014) Level of agreement between 2002 American–European Consensus Group and 2012 American College of Rheumatology classification criteria for Sjögren’s syndrome and reasons for discrepancies. Arthritis Res Ther 16:R74PubMedCentralCrossRefPubMed Cornec D, Saraux A, Cochener B et al (2014) Level of agreement between 2002 American–European Consensus Group and 2012 American College of Rheumatology classification criteria for Sjögren’s syndrome and reasons for discrepancies. Arthritis Res Ther 16:R74PubMedCentralCrossRefPubMed
11.
go back to reference Cornec D, Jamin C, Pers J-O (2014) Sjögren’s syndrome: where do we stand, and where shall we go? J Autoimmun 51:109–114CrossRefPubMed Cornec D, Jamin C, Pers J-O (2014) Sjögren’s syndrome: where do we stand, and where shall we go? J Autoimmun 51:109–114CrossRefPubMed
12.
go back to reference Cornec D, Devauchelle-Pensec V, Tobón GJ, Pers J-O, Jousse-Joulin S, Saraux A (2012) B cells in Sjögren’s syndrome: from pathophysiology to diagnosis and treatment. J Autoimmun 39:161–167CrossRefPubMed Cornec D, Devauchelle-Pensec V, Tobón GJ, Pers J-O, Jousse-Joulin S, Saraux A (2012) B cells in Sjögren’s syndrome: from pathophysiology to diagnosis and treatment. J Autoimmun 39:161–167CrossRefPubMed
13.
go back to reference Berthelot J-M, Jamin C, Amrouche K, Le Goff B, Maugars Y, Youinou P (2013) Regulatory B cells play a key role in immune system balance. Jt Bone Spine 80:18–22CrossRef Berthelot J-M, Jamin C, Amrouche K, Le Goff B, Maugars Y, Youinou P (2013) Regulatory B cells play a key role in immune system balance. Jt Bone Spine 80:18–22CrossRef
14.
go back to reference Cornec D, Saraux A, Devauchelle-Pensec V, Clodic C, Pers J-O (2013) The future of B cell-targeted therapies in Sjögren’s syndrome. Immunotherapy 5:639–646CrossRefPubMed Cornec D, Saraux A, Devauchelle-Pensec V, Clodic C, Pers J-O (2013) The future of B cell-targeted therapies in Sjögren’s syndrome. Immunotherapy 5:639–646CrossRefPubMed
15.
go back to reference Tobón GJ, Pers JO, Youinou P, Saraux A (2010) B cell-targeted therapies in Sjögren’s syndrome. Autoimmun Rev 9:224–228CrossRefPubMed Tobón GJ, Pers JO, Youinou P, Saraux A (2010) B cell-targeted therapies in Sjögren’s syndrome. Autoimmun Rev 9:224–228CrossRefPubMed
16.
go back to reference McCarty CA, Bansal AK, Livingston PM, Stanislavsky YL, Taylor HR (1998) The epidemiology of dry eye in Melbourne, Australia. Ophthalmology 105:1114–1119CrossRefPubMed McCarty CA, Bansal AK, Livingston PM, Stanislavsky YL, Taylor HR (1998) The epidemiology of dry eye in Melbourne, Australia. Ophthalmology 105:1114–1119CrossRefPubMed
17.
go back to reference Lin P-Y, Tsai S-Y, Cheng C-Y, Liu J-H, Chou P, Hsu W-M (2003) Prevalence of dry eye among an elderly Chinese population in Taiwan: the Shihpai Eye Study. Ophthalmology 110:1096–1101CrossRefPubMed Lin P-Y, Tsai S-Y, Cheng C-Y, Liu J-H, Chou P, Hsu W-M (2003) Prevalence of dry eye among an elderly Chinese population in Taiwan: the Shihpai Eye Study. Ophthalmology 110:1096–1101CrossRefPubMed
18.
go back to reference Schaumberg DA, Sullivan DA, Buring JE, Dana MR (2003) Prevalence of dry eye syndrome among US women. Am J Ophthalmol 136:318–326CrossRefPubMed Schaumberg DA, Sullivan DA, Buring JE, Dana MR (2003) Prevalence of dry eye syndrome among US women. Am J Ophthalmol 136:318–326CrossRefPubMed
19.
go back to reference Moss SE, Klein R, Klein BE (2000) Prevalence of and risk factors for dry eye syndrome. Arch Ophthalmol 118:1264–1268CrossRefPubMed Moss SE, Klein R, Klein BE (2000) Prevalence of and risk factors for dry eye syndrome. Arch Ophthalmol 118:1264–1268CrossRefPubMed
20.
go back to reference O’Brien PD, Collum LMT (2004) Dry eye: diagnosis and current treatment strategies. Curr Allergy Asthma Rep 4:314–319CrossRefPubMed O’Brien PD, Collum LMT (2004) Dry eye: diagnosis and current treatment strategies. Curr Allergy Asthma Rep 4:314–319CrossRefPubMed
21.
go back to reference Orellana MF, Lagravère MO, Boychuk DGJ, Major PW, Flores-Mir C (2006) Prevalence of xerostomia in population-based samples: a systematic review. J Public Health Dent 66:152–158CrossRefPubMed Orellana MF, Lagravère MO, Boychuk DGJ, Major PW, Flores-Mir C (2006) Prevalence of xerostomia in population-based samples: a systematic review. J Public Health Dent 66:152–158CrossRefPubMed
22.
go back to reference Ikebe K, Nokubi T, Sajima H et al (2001) Perception of dry mouth in a sample of community-dwelling older adults in Japan. Spec Care Dent Off Publ Am Assoc Hosp Dent Acad Dent Handicap Am Soc Geriatr Dent 21:52–59 Ikebe K, Nokubi T, Sajima H et al (2001) Perception of dry mouth in a sample of community-dwelling older adults in Japan. Spec Care Dent Off Publ Am Assoc Hosp Dent Acad Dent Handicap Am Soc Geriatr Dent 21:52–59
23.
go back to reference Nederfors T, Isaksson R, Mörnstad H, Dahlöf C (1997) Prevalence of perceived symptoms of dry mouth in an adult Swedish population—relation to age, sex and pharmacotherapy. Community Dent Oral Epidemiol 25:211–216CrossRefPubMed Nederfors T, Isaksson R, Mörnstad H, Dahlöf C (1997) Prevalence of perceived symptoms of dry mouth in an adult Swedish population—relation to age, sex and pharmacotherapy. Community Dent Oral Epidemiol 25:211–216CrossRefPubMed
24.
go back to reference Billings RJ, Proskin HM, Moss ME (1996) Xerostomia and associated factors in a community-dwelling adult population. Community Dent Oral Epidemiol 24:312–316CrossRefPubMed Billings RJ, Proskin HM, Moss ME (1996) Xerostomia and associated factors in a community-dwelling adult population. Community Dent Oral Epidemiol 24:312–316CrossRefPubMed
25.
go back to reference Pajukoski H, Meurman JH, Halonen P, Sulkava R (2001) Prevalence of subjective dry mouth and burning mouth in hospitalized elderly patients and outpatients in relation to saliva, medication, and systemic diseases. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 92:641–649CrossRefPubMed Pajukoski H, Meurman JH, Halonen P, Sulkava R (2001) Prevalence of subjective dry mouth and burning mouth in hospitalized elderly patients and outpatients in relation to saliva, medication, and systemic diseases. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 92:641–649CrossRefPubMed
26.
go back to reference Duquenne C, Cornec D, Pers J-O et al (2013) Current diagnostic tools for Sjögren’s syndrome. Int J Clin Rheumatol 8:281–290CrossRef Duquenne C, Cornec D, Pers J-O et al (2013) Current diagnostic tools for Sjögren’s syndrome. Int J Clin Rheumatol 8:281–290CrossRef
27.
28.
go back to reference Whitcher JP, Shiboski CH, Shiboski SC et al (2010) A simplified quantitative method for assessing keratoconjunctivitis sicca from the Sjögren’s Syndrome International Registry. Am J Ophthalmol 149:405–415PubMedCentralCrossRefPubMed Whitcher JP, Shiboski CH, Shiboski SC et al (2010) A simplified quantitative method for assessing keratoconjunctivitis sicca from the Sjögren’s Syndrome International Registry. Am J Ophthalmol 149:405–415PubMedCentralCrossRefPubMed
29.
go back to reference Speight PM, Kaul A, Melsom RD (1992) Measurement of whole unstimulated salivary flow in the diagnosis of Sjögren’s syndrome. Ann Rheum Dis 51:499–502PubMedCentralCrossRefPubMed Speight PM, Kaul A, Melsom RD (1992) Measurement of whole unstimulated salivary flow in the diagnosis of Sjögren’s syndrome. Ann Rheum Dis 51:499–502PubMedCentralCrossRefPubMed
30.
go back to reference Jorkjend L, Johansson A, Johansson A-K, Bergenholtz A (2004) Resting and stimulated whole salivary flow rates in Sjögren’s syndrome patients over time: a diagnostic aid for subsidized dental care? Acta Odontol Scand 62:264–268CrossRefPubMed Jorkjend L, Johansson A, Johansson A-K, Bergenholtz A (2004) Resting and stimulated whole salivary flow rates in Sjögren’s syndrome patients over time: a diagnostic aid for subsidized dental care? Acta Odontol Scand 62:264–268CrossRefPubMed
31.
go back to reference Bookman AAM, Shen H, Cook RJ et al (2011) Whole stimulated salivary flow: correlation with the pathology of inflammation and damage in minor salivary gland biopsy specimens from patients with primary Sjögren’s syndrome but not patients with sicca. Arthritis Rheum 63:2014–2020CrossRefPubMed Bookman AAM, Shen H, Cook RJ et al (2011) Whole stimulated salivary flow: correlation with the pathology of inflammation and damage in minor salivary gland biopsy specimens from patients with primary Sjögren’s syndrome but not patients with sicca. Arthritis Rheum 63:2014–2020CrossRefPubMed
32.
go back to reference Pijpe J, van Imhoff GW, Spijkervet FKL et al (2005) Rituximab treatment in patients with primary Sjögren’s syndrome: an open-label phase II study. Arthritis Rheum 52:2740–2750CrossRefPubMed Pijpe J, van Imhoff GW, Spijkervet FKL et al (2005) Rituximab treatment in patients with primary Sjögren’s syndrome: an open-label phase II study. Arthritis Rheum 52:2740–2750CrossRefPubMed
33.
go back to reference Ramos-Casals M, Brito-Zerón P, Perez-DE-Lis M et al (2010) Clinical and prognostic significance of parotid scintigraphy in 405 patients with primary Sjogren’s syndrome. J Rheumatol 37:585–590CrossRefPubMed Ramos-Casals M, Brito-Zerón P, Perez-DE-Lis M et al (2010) Clinical and prognostic significance of parotid scintigraphy in 405 patients with primary Sjogren’s syndrome. J Rheumatol 37:585–590CrossRefPubMed
34.
go back to reference Tonami H, Higashi K, Matoba M, Yokota H, Yamamoto I, Sugai S (2001) A comparative study between MR sialography and salivary gland scintigraphy in the diagnosis of Sjögren syndrome. J Comput Assist Tomogr 25:262–268CrossRefPubMed Tonami H, Higashi K, Matoba M, Yokota H, Yamamoto I, Sugai S (2001) A comparative study between MR sialography and salivary gland scintigraphy in the diagnosis of Sjögren syndrome. J Comput Assist Tomogr 25:262–268CrossRefPubMed
35.
go back to reference Daniels TE, Benn DK (1996) Is sialography effective in diagnosing the salivary component of Sjögren’s syndrome? Adv Dent Res 10:25–28CrossRefPubMed Daniels TE, Benn DK (1996) Is sialography effective in diagnosing the salivary component of Sjögren’s syndrome? Adv Dent Res 10:25–28CrossRefPubMed
36.
go back to reference Cornec D, Jousse-Joulin S, Pers J-O et al (2013) Contribution of salivary gland ultrasonography to the diagnosis of Sjögren’s syndrome: toward new diagnostic criteria? Arthritis Rheum 65:216–225CrossRefPubMed Cornec D, Jousse-Joulin S, Pers J-O et al (2013) Contribution of salivary gland ultrasonography to the diagnosis of Sjögren’s syndrome: toward new diagnostic criteria? Arthritis Rheum 65:216–225CrossRefPubMed
37.
go back to reference De Vita S, Lorenzon G, Rossi G, Sabella M, Fossaluzza V (1992) Salivary gland echography in primary and secondary Sjögren’s syndrome. Clin Exp Rheumatol 10:351–356PubMed De Vita S, Lorenzon G, Rossi G, Sabella M, Fossaluzza V (1992) Salivary gland echography in primary and secondary Sjögren’s syndrome. Clin Exp Rheumatol 10:351–356PubMed
38.
go back to reference Cornec D, Jousse-Joulin S, Marhadour T et al (2014) Salivary gland ultrasonography improves the diagnostic performance of the 2012 American College of Rheumatology classification criteria for Sjögren’s syndrome. Rheumatology keu037 Cornec D, Jousse-Joulin S, Marhadour T et al (2014) Salivary gland ultrasonography improves the diagnostic performance of the 2012 American College of Rheumatology classification criteria for Sjögren’s syndrome. Rheumatology keu037
39.
go back to reference Daniels TE (1984) Labial salivary gland biopsy in Sjögren’s syndrome. Assessment as a diagnostic criterion in 362 suspected cases. Arthritis Rheum 27:147–156CrossRefPubMed Daniels TE (1984) Labial salivary gland biopsy in Sjögren’s syndrome. Assessment as a diagnostic criterion in 362 suspected cases. Arthritis Rheum 27:147–156CrossRefPubMed
41.
go back to reference Guellec D, Cornec D, Jousse-Joulin S et al (2013) Diagnostic value of labial minor salivary gland biopsy for Sjögren’s syndrome: a systematic review. Autoimmun Rev 12:416–420CrossRefPubMed Guellec D, Cornec D, Jousse-Joulin S et al (2013) Diagnostic value of labial minor salivary gland biopsy for Sjögren’s syndrome: a systematic review. Autoimmun Rev 12:416–420CrossRefPubMed
42.
go back to reference Pijpe J, Kalk WWI, van der Wal JE et al (2007) Parotid gland biopsy compared with labial biopsy in the diagnosis of patients with primary Sjögren’s syndrome. Rheumatology 46:335–341CrossRefPubMed Pijpe J, Kalk WWI, van der Wal JE et al (2007) Parotid gland biopsy compared with labial biopsy in the diagnosis of patients with primary Sjögren’s syndrome. Rheumatology 46:335–341CrossRefPubMed
43.
go back to reference Pollard RPE, Pijpe J, Bootsma H et al (2011) Treatment of mucosa-associated lymphoid tissue lymphoma in Sjogren’s syndrome: a retrospective clinical study. J Rheumatol 38:2198–2208CrossRefPubMed Pollard RPE, Pijpe J, Bootsma H et al (2011) Treatment of mucosa-associated lymphoid tissue lymphoma in Sjogren’s syndrome: a retrospective clinical study. J Rheumatol 38:2198–2208CrossRefPubMed
44.
go back to reference Doan S (2009) Atteinte oculaire et environnement : clinique et physiopathologie. Rev Fr Allergol 49:416–419CrossRef Doan S (2009) Atteinte oculaire et environnement : clinique et physiopathologie. Rev Fr Allergol 49:416–419CrossRef
45.
go back to reference Van Zuuren EJ, Kramer S, Carter B, Graber MA, Fedorowicz Z (2011) A Interventions for rosacea. Cochrane Database Syst Rev CD003262 Van Zuuren EJ, Kramer S, Carter B, Graber MA, Fedorowicz Z (2011) A Interventions for rosacea. Cochrane Database Syst Rev CD003262
46.
go back to reference Gilboe IM, Kvien TK, Uhlig T, Husby G (2001) Sicca symptoms and secondary Sjögren’s syndrome in systemic lupus erythematosus: comparison with rheumatoid arthritis and correlation with disease variables. Ann Rheum Dis 60:1103–1109PubMedCentralCrossRefPubMed Gilboe IM, Kvien TK, Uhlig T, Husby G (2001) Sicca symptoms and secondary Sjögren’s syndrome in systemic lupus erythematosus: comparison with rheumatoid arthritis and correlation with disease variables. Ann Rheum Dis 60:1103–1109PubMedCentralCrossRefPubMed
47.
go back to reference Avouac J, Sordet C, Depinay C et al (2006) Systemic sclerosis-associated Sjögren’s syndrome and relationship to the limited cutaneous subtype: results of a prospective study of sicca syndrome in 133 consecutive patients. Arthritis Rheum 54:2243–2249CrossRefPubMed Avouac J, Sordet C, Depinay C et al (2006) Systemic sclerosis-associated Sjögren’s syndrome and relationship to the limited cutaneous subtype: results of a prospective study of sicca syndrome in 133 consecutive patients. Arthritis Rheum 54:2243–2249CrossRefPubMed
48.
go back to reference Brun JG, Madland TM, Jonsson R (2003) A prospective study of sicca symptoms in patients with rheumatoid arthritis. Arthritis Rheum 49:187–192CrossRefPubMed Brun JG, Madland TM, Jonsson R (2003) A prospective study of sicca symptoms in patients with rheumatoid arthritis. Arthritis Rheum 49:187–192CrossRefPubMed
49.
go back to reference Binard A, Le Pottier L, Devauchelle-Pensec V, Saraux A, Youinou P, Pers J-O (2009) Is the blood B-cell subset profile diagnostic for Sjogren syndrome? Ann Rheum Dis 68:1447–1452PubMedCentralCrossRefPubMed Binard A, Le Pottier L, Devauchelle-Pensec V, Saraux A, Youinou P, Pers J-O (2009) Is the blood B-cell subset profile diagnostic for Sjogren syndrome? Ann Rheum Dis 68:1447–1452PubMedCentralCrossRefPubMed
50.
go back to reference Cornec D, Saraux A, Pers J-O et al (2014) Diagnostic accuracy of blood B-cell subset profiling and autoimmunity markers in Sjögren’s syndrome. Arthritis Res Ther 16:R15PubMedCentralCrossRefPubMed Cornec D, Saraux A, Pers J-O et al (2014) Diagnostic accuracy of blood B-cell subset profiling and autoimmunity markers in Sjögren’s syndrome. Arthritis Res Ther 16:R15PubMedCentralCrossRefPubMed
51.
go back to reference Ramos-Casals M, Brito-Zerón P, García-Carrasco M, Font J (2004) Sarcoidosis or Sjögren syndrome? Clues to defining mimicry or coexistence in 59 cases. Medicine (Baltimore) 83:85–95CrossRef Ramos-Casals M, Brito-Zerón P, García-Carrasco M, Font J (2004) Sarcoidosis or Sjögren syndrome? Clues to defining mimicry or coexistence in 59 cases. Medicine (Baltimore) 83:85–95CrossRef
52.
go back to reference Imanguli MM, Atkinson JC, Mitchell SA et al (2010) Salivary gland involvement in chronic graft-versus-host disease: prevalence, clinical significance, and recommendations for evaluation. Biol Blood Marrow Transplant 16:1362–1369PubMedCentralCrossRefPubMed Imanguli MM, Atkinson JC, Mitchell SA et al (2010) Salivary gland involvement in chronic graft-versus-host disease: prevalence, clinical significance, and recommendations for evaluation. Biol Blood Marrow Transplant 16:1362–1369PubMedCentralCrossRefPubMed
53.
go back to reference Guchelaar HJ, Vermes A, Meerwaldt JH (1997) Radiation-induced xerostomia: pathophysiology, clinical course and supportive treatment. Support Care Cancer Off J Multinatl Assoc Support Care Cancer 5:281–288 Guchelaar HJ, Vermes A, Meerwaldt JH (1997) Radiation-induced xerostomia: pathophysiology, clinical course and supportive treatment. Support Care Cancer Off J Multinatl Assoc Support Care Cancer 5:281–288
55.
go back to reference Eisbruch A, Ten Haken RK, Kim HM, Marsh LH, Ship JA (1999) Dose, volume, and function relationships in parotid salivary glands following conformal and intensity-modulated irradiation of head and neck cancer. Int J Radiat Oncol Biol Phys 45:577–587CrossRefPubMed Eisbruch A, Ten Haken RK, Kim HM, Marsh LH, Ship JA (1999) Dose, volume, and function relationships in parotid salivary glands following conformal and intensity-modulated irradiation of head and neck cancer. Int J Radiat Oncol Biol Phys 45:577–587CrossRefPubMed
56.
57.
58.
go back to reference Moore PA, Guggenheimer J, Etzel KR, Weyant RJ, Orchard T (2001) Type 1 diabetes mellitus, xerostomia, and salivary flow rates. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 92:281–291CrossRefPubMed Moore PA, Guggenheimer J, Etzel KR, Weyant RJ, Orchard T (2001) Type 1 diabetes mellitus, xerostomia, and salivary flow rates. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 92:281–291CrossRefPubMed
59.
go back to reference Botsios C, Furlan A, Ostuni P et al (2011) Elderly onset of primary Sjögren’s syndrome: clinical manifestations, serological features and oral/ocular diagnostic tests. Comparison with adult and young onset of the disease in a cohort of 336 Italian patients. Jt Bone Spine Rev Rhum 78:171–174CrossRef Botsios C, Furlan A, Ostuni P et al (2011) Elderly onset of primary Sjögren’s syndrome: clinical manifestations, serological features and oral/ocular diagnostic tests. Comparison with adult and young onset of the disease in a cohort of 336 Italian patients. Jt Bone Spine Rev Rhum 78:171–174CrossRef
60.
go back to reference Versura P, Campos EC (2005) Menopause and dry eye. A possible relationship. Gynecol Endocrinol Off J Int Soc Gynecol Endocrinol 20:289–298CrossRef Versura P, Campos EC (2005) Menopause and dry eye. A possible relationship. Gynecol Endocrinol Off J Int Soc Gynecol Endocrinol 20:289–298CrossRef
61.
go back to reference Lemos-Júnior CA, Camargo A (2011) Images in clinical medicine. Sialolith of the submandibular salivary gland. N Engl J Med 364:551CrossRefPubMed Lemos-Júnior CA, Camargo A (2011) Images in clinical medicine. Sialolith of the submandibular salivary gland. N Engl J Med 364:551CrossRefPubMed
62.
63.
go back to reference Takahashi H, Yamamoto M, Suzuki C, Naishiro Y, Shinomura Y, Imai K (2010) The birthday of a new syndrome: IgG4-related diseases constitute a clinical entity. Autoimmun Rev 9:591–594CrossRefPubMed Takahashi H, Yamamoto M, Suzuki C, Naishiro Y, Shinomura Y, Imai K (2010) The birthday of a new syndrome: IgG4-related diseases constitute a clinical entity. Autoimmun Rev 9:591–594CrossRefPubMed
64.
go back to reference Palazzo E, Palazzo C, Palazzo M (2013) IgG4-related disease. Jt Bone Spine Rev Rhum Palazzo E, Palazzo C, Palazzo M (2013) IgG4-related disease. Jt Bone Spine Rev Rhum
65.
go back to reference Trimarchi M, Sinico RA, Teggi R, Bussi M, Specks U, Meroni PL (2013) Otorhinolaryngological manifestations in granulomatosis with polyangiitis (Wegener’s). Autoimmun Rev 12:501–505CrossRefPubMed Trimarchi M, Sinico RA, Teggi R, Bussi M, Specks U, Meroni PL (2013) Otorhinolaryngological manifestations in granulomatosis with polyangiitis (Wegener’s). Autoimmun Rev 12:501–505CrossRefPubMed
66.
go back to reference Kim D, Uy C, Mandel L (1998) Sialosis of unknown origin. N Y State Dent J 64:38–40PubMed Kim D, Uy C, Mandel L (1998) Sialosis of unknown origin. N Y State Dent J 64:38–40PubMed
67.
go back to reference Romanos GE, Javed F, Romanos EB, Williams RC (2012) Oro-facial manifestations in patients with eating disorders. Appetite 59:499–504CrossRefPubMed Romanos GE, Javed F, Romanos EB, Williams RC (2012) Oro-facial manifestations in patients with eating disorders. Appetite 59:499–504CrossRefPubMed
Metadata
Title
The Differential Diagnosis of Dry Eyes, Dry Mouth, and Parotidomegaly: A Comprehensive Review
Authors
Divi Cornec
Alain Saraux
Sandrine Jousse-Joulin
Jacques-Olivier Pers
Sylvie Boisramé-Gastrin
Yves Renaudineau
Yves Gauvin
Anne-Marie Roguedas-Contios
Steeve Genestet
Myriam Chastaing
Béatrice Cochener
Valérie Devauchelle-Pensec
Publication date
01-12-2015
Publisher
Springer US
Published in
Clinical Reviews in Allergy & Immunology / Issue 3/2015
Print ISSN: 1080-0549
Electronic ISSN: 1559-0267
DOI
https://doi.org/10.1007/s12016-014-8431-1

Other articles of this Issue 3/2015

Clinical Reviews in Allergy & Immunology 3/2015 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.